지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder defined by impairing levels of inattention, disorganization, and/or hyperactivity-impulsivity. ADHD often persists into adulthood, with resultant impairments of social, academic and occupational functioning. ADHD is a very common disease during childhood and, the pooled overall prevalence of ADHD was found to be 5.29%. When screening for ADHD, clinicians should try to develop rapport with patients and their caregivers to increase the likelihood that they will follow the diagnostic process and treatment. The current drugs that have received Food and Drug Administration-approval for ADHD include stimulants (methylphenidate and dextroamphetamine) and non-stimulants (atomoxetine, guanfacine, and clonidine). Stimulants improve inattention, hyperactivity, and impulsivity in addition to decreasing disruptive behaviors and promoting academic achievement and the maintenance of appropriate friendships. In order to enhance drug compliance, the use of long-acting stimulants is increasing. Atomoxetine is a selective norepinephrine reuptake blocker, the effects of which may take 2 to 6 weeks to be noticeable. Furthermore, α2 agonists may help to improve behavioral side effects, tics, and sleep problems during stimulant or atomoxetine use. Common side effects of stimulants and atomoxetine include headache, stomachache, and loss of appetite. Routine electorcardiography before medication is not recommended unless there is a specific indication. Methylphenidate and atomoxetine are safe as first line therapies, and their side effects are well tolerated.
목차
등록된 정보가 없습니다.
참고문헌 (40)
참고문헌 신청
Pliszka S / 2007 / Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder / J Am Acad Child Adolesc Psychiatry 46:894~921
American Psychiatric Association / 2013 / Diagnostic and statistical manual of mental disorders: DSM-5 / Ame-rican Psychiatric Association
Polanczyk G / 2007 / The worldwide prevalence of ADHD : a systematic review and metaregression analysis / Am J Psychiatry 164:942~948
Molina BS / 2009 / The MTA at 8 years : prospective follow-up of children treated for combined-type ADHD in a multisite study / J Am Acad Child Adolesc Psychiatry 48:484~500
Barkley RA / 1990 / The adole-scent outcome of hyperactive children diagnosed by research criteria : I : an 8-year prospective follow-up study / J Am Acad Child Adolesc Psychiatry 29:546~557
American Psychiatric Association / 2013 / Diagnostic and statistical manual of mental disorders: DSM-5 / Ame-rican Psychiatric Association
Polanczyk G / 2007 / The worldwide prevalence of ADHD : a systematic review and metaregression analysis / Am J Psychiatry 164:942~948
Molina BS / 2009 / The MTA at 8 years : prospective follow-up of children treated for combined-type ADHD in a multisite study / J Am Acad Child Adolesc Psychiatry 48:484~500
Barkley RA / 1990 / The adole-scent outcome of hyperactive children diagnosed by research criteria : I : an 8-year prospective follow-up study / J Am Acad Child Adolesc Psychiatry 29:546~557
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
소아청소년정신의학
2022 .04
-
Treatment of Children and Adolescents with Epilepsy with Atomoxetine
PSYCHIATRY INVESTIGATION
2020 .01
-
성인 주의력결핍과잉행동장애의 약물치료
대한의사협회지
2021 .01
-
A Brief Replication Study Comparing Stimulants and Non-Stimulants for Attention-Deficit/Hyperactivity Disorder Treatment with a Focus on the Compliance, Efficacy, and Satisfaction
소아청소년정신의학
2021 .01
-
Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
Clinical Psychopharmacology and Neuroscience
2021 .11
-
주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(Ⅲ) : 약물치료
소아청소년정신의학
2017 .04
-
Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder
소아청소년정신의학
2019 .04
-
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
Clinical Psychopharmacology and Neuroscience
2020 .01
-
Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion
Journal of Clinical Neurology
2023 .03
-
A Review and an Update on Pharmacological Treatment of Children With Attention-Deficit/Hyperactivity Disorder
소아청소년정신의학
2025 .01
-
Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
PSYCHIATRY INVESTIGATION
2018 .01
-
Effectiveness of Stimulant Medications on Disruptive Behavior and Mood Problems in Young Children
Clinical Psychopharmacology and Neuroscience
2020 .01
-
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report
Clinical Psychopharmacology and Neuroscience
2015 .01
-
국내 주의력결핍 과잉행동 장애 아동 및 청소년의 약물요법 패턴 및 지속성
한국임상약학회지
2018 .01
-
Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose Aripiprazole
Clinical Psychopharmacology and Neuroscience
2016 .01
-
The Effectiveness of Methylphenidate in the Treatment of Encopresis Independent from Attention-Deficit Hyperactivity Disorder Symptoms
PSYCHIATRY INVESTIGATION
2015 .01
-
Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
Clinical Psychopharmacology and Neuroscience
2016 .01
-
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database
Journal of Korean Medical Science
2016 .01
-
국민건강보험 데이터베이스를 이용한 한국의 소아와 성인에서 주의력결핍 과잉행동장애의 진단율 및 약물 사용 추세 연구
신경정신의학
2021 .11
-
주의력결핍 과잉행동장애 아동의 약물치료가 운동협응력에 미치는 효과 : 개방연구
소아청소년정신의학
2017 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0